Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Japon And NotAyako Harashima

List of bibliographic references

Number of relevant bibliographic references: 47.
Ident.Authors (with country if any)Title
000035 Miyuki Kawase [Japon] ; Kazuya Shirato [Japon] ; Lia Van Der Hoek [Pays-Bas] ; Fumihiro Taguchi [Japon] ; Shutoku Matsuyama [Japon]Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry
000036 Tomohisa Tanaka [Japon] ; Wataru Kamitani [Japon] ; Marta L. Dediego [Espagne] ; Luis Enjuanes [Espagne] ; Yoshiharu Matsuura [Japon]Severe Acute Respiratory Syndrome Coronavirus nsp1 Facilitates Efficient Propagation in Cells through a Specific Translational Shutoff of Host mRNA
000046 Masaya Fukushi [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Yusuke Matsuoka [Japon] ; Seisuke Hatakeyama [Japon] ; Yukihito Ishizaka [Japon] ; Teruo Kirikae [Japon] ; Takehiko Sasazuki [Japon] ; Tohru Miyoshi-Akiyama [Japon]Monitoring of S Protein Maturation in the Endoplasmic Reticulum by Calnexin Is Important for the Infectivity of Severe Acute Respiratory Syndrome Coronavirus
000058 Shumpei Tsuda [Japon] ; Shumpei Watanabe [Japon] ; Joseph S. Masangkay [Philippines] ; Tetsuya Mizutani [Japon] ; Phillip Alviola [Philippines] ; Naoya Ueda [Japon] ; Koichiro Iha [Japon] ; Satoshi Taniguchi [Japon] ; Hikaru Fujii [Japon] ; Kentaro Kato [Japon] ; Taisuke Horimoto [Japon] ; Shigeru Kyuwa [Japon] ; Yasuhiro Yoshikawa [Japon] ; Hiroomi Akashi [Japon]Genomic and serological detection of bat coronavirus from bats in the Philippines
000095 Tohru Miyoshi-Akiyama [Japon] ; Isao Ishida [Japon] ; Masaya Fukushi [Japon] ; Keina Yamaguchi [Japon] ; Yusuke Matsuoka [Japon] ; Takashi Ishihara [Japon] ; Masayoshi Tsukahara [Japon] ; Seisuke Hatakeyama [Japon] ; Norikazu Itoh [Japon] ; Aki Morisawa [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Naoki Yamamoto [Japon] ; ZHANG LIANFENG [République populaire de Chine] ; QIN CHUAN [République populaire de Chine] ; Teruo Kirikae [Japon] ; Takehiko Sasazuki [Japon]Fully Human Monoclonal Antibody Directed to Proteolytic Cleavage Site in Severe Acute Respiratory Syndrome (SARS) Coronavirus S Protein Neutralizes the Virus in a Rhesus Macaque SARS Model
000125 Shiori Haga [Japon] ; Noriyo Nagata [Japon] ; Tadashi Okamura [Japon] ; Norio Yamamoto [Japon] ; Tetsutaro Sata [Japon] ; Naoki Yamamoto [Japon] ; Takehiko Sasazuki [Japon] ; Yukihito Ishizaka [Japon]TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds
000139 JUN LIU [République populaire de Chine] ; PENG WU [République populaire de Chine] ; FENG GAO [République populaire de Chine] ; JIANXUN QI [République populaire de Chine] ; Ai Kawana-Tachikawa [Japon] ; JING XIE [République populaire de Chine] ; Christopher J. Vavricka [République populaire de Chine] ; Aikichi Iwamoto [Japon] ; TAISHENG LI [République populaire de Chine] ; George F. Gao [République populaire de Chine]Novel Immunodominant Peptide Presentation Strategy: a Featured HLA-A* 2402-Restricted Cytotoxic T-Lymphocyte Epitope Stabilized by Intrachain Hydrogen Bonds from Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein
000151 Shutoku Matsuyama [Japon] ; Noriyo Nagata [Japon] ; Kazuya Shirato [Japon] ; Miyuki Kawase [Japon] ; Makoto Takeda [Japon] ; Fumihiro Taguchi [Japon]Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
000172 Shutoku Matsuyama [Japon] ; Fumihiro Taguchi [Japon]Two-Step Conformational Changes in a Coronavirus Envelope Glycoprotein Mediated by Receptor Binding and Proteolysis
000180 Satoshi Ohno [Japon] ; Shunsuke Kohyama [Japon] ; Maiko Taneichi [Japon] ; Osamu Moriya [Japon] ; Hidenori Hayashi [Japon] ; Hiroshi Oda [Japon] ; Masahito Mori [Japon] ; Akiharu Kobayashi [Japon] ; Toshitalca Akatsuka [Japon] ; Tetsuya Uchida [Japon] ; Masanori Matsui [Japon]Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice
000195 Miyuki Kawase [Japon] ; Kazuya Shirato [Japon] ; Shutoku Matsuyama [Japon] ; Fumihiro Taguchi [Japon]Protease-Mediated Entry via the Endosome of Human Coronavirus 229E
000196 MIN ZHUANG [Japon, République populaire de Chine] ; HONG JIANG [République populaire de Chine] ; Yasuhiro Suzuki [Japon] ; XIAOGUANG LI [Japon] ; PENG XIAO [Japon] ; Takashi Tanaka [Japon] ; HONG LING [République populaire de Chine] ; BAOFENG YANG [République populaire de Chine] ; Hiroki Saitoh [Japon] ; LIANFENG ZHANG [République populaire de Chine] ; CHUAN QIN [République populaire de Chine] ; Kazuo Sugamura [Japon] ; Toshio Hattori [Japon]Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection
000197 Saemi Obitsu [Japon] ; Nursarat Ahmed [Japon] ; Hironori Nishitsuji [Japon] ; Atsuhiko Hasegawa [Japon] ; Ken-Ichi Nakahama [Japon] ; Ikuo Morita [Japon] ; Kazuo Nishigaki [Japon] ; Takaya Hayashi [Japon] ; Takao Masuda [Japon] ; Mari Kannagi [Japon]Potential enhancement of osteoclastogenesis by severe acute respiratory syndrome coronavirus 3a/X1 protein
000201 Thomas Regnier [Japon] ; Diganta Sarma [Japon] ; Koushi Hidaka [Japon] ; Usman Bacha [États-Unis] ; Ernesto Freire [États-Unis] ; Yoshio Hayashi [Japon] ; Yoshiaki Kiso [Japon]New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CLpro inhibitors
000213 Shunsuke Kohyama [Japon] ; Satoshi Ohno [Japon] ; Tatsuya Suda [Japon] ; Maiko Taneichi [Japon] ; Shoichi Yokoyama [Japon] ; Masahito Mori [Japon] ; Akiharu Kobavashi [Japon] ; Hidenori Havashi [Japon] ; Tetsuva Uchida [Japon] ; Masanori Matsui [Japon]Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a
000256 Kotaro Fujimoto [Japon] ; Kwok-Hung Chan [Hong Kong] ; Kazuhiko Takeda [Japon] ; Kam-Fai Lo [Hong Kong] ; Raymond H. K. Leung [Hong Kong] ; Takashi Okamoto [Japon]Sensitive and Specific Enzyme-Linked Immunosorbent Assay Using Chemiluminescence for Detection of Severe Acute Respiratory Syndrome Viral Infection
000284 Kenichi Akaji [Japon] ; Hiroyuki Konno [Japon] ; Mari Onozuka [Japon] ; Ayumi Makino [Japon] ; Hiroyuki Saito [Japon] ; Kazuto Nosaka [Japon]Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL protease as a proteolysis-resistant mutant
000285 Rie Watanabe [Japon] ; Shutoku Matsuyama [Japon] ; Kazuya Shirato [Japon] ; Masami Maejima [Japon] ; Shuetsu Fukushi [Japon] ; Shigeru Morikawa [Japon] ; Fumihiro Taguchi [Japon]Entry from the Cell Surface of Severe Acute Respiratory Syndrome Coronavirus with Cleaved S Protein as Revealed by Pseudotype Virus Bearing Cleaved S Protein
000289 Hyun-Kyoung Lee [Corée du Sud] ; Byoung-Hee Lee [Corée du Sud] ; NOTONKUMAR DUTTA [Corée du Sud] ; Seung-Hyeok Seok [Corée du Sud] ; Min-Won Back [Corée du Sud] ; Hui-Young Lee [Corée du Sud] ; Dong-Jae Kim [Corée du Sud] ; Yi-Rang Na [Corée du Sud] ; Kyoung-Jin Noh [Corée du Sud] ; Sung-Hoon Park [Corée du Sud] ; Hiroaki Kariwa [Japon] ; Mina Nakauchi [Japon] ; LE QUYNH MAI [Viêt Nam] ; Suk-Jin Heo [Corée du Sud] ; Jae-Hak Park [Corée du Sud]Detection of Antibodies Against SARS-Coronavirus Using Recombinant Truncated Nucleocapsid Proteins by ELISA
000299 Yu-Ya Mitsuki [Japon] ; Kazuo Ohnishi [Japon] ; Hirotaka Takagi [Japon] ; Masamichi Oshima [Japon] ; Takuya Yamamoto [Japon] ; Fuminori Mizukoshi [Japon] ; Kazutaka Terahara [Japon] ; Kazuo Kobayashi [Japon] ; Naoki Yamamoto [Japon] ; Shoji Yamaoka [Japon] ; Yasuko Tsunetsugu-Yokota [Japon]A single amino acid substitution in the Sl and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV
000329 Masahiro Ikejiri [Japon] ; Masayuki Saijo [Japon] ; Shigeru Morikawa [Japon] ; Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Ichiro Kurane [Japon] ; Tokumi Maruyama [Japon]Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents
000345 Masahiro Kitabatake [Japon] ; Shingo Inoue [Japon] ; Fumihiko Yasui [Japon] ; Shoji Yokochi [Japon] ; Masaaki Arai [Japon] ; Kouichi Morita [Japon] ; Hisatoshi Shida [Japon] ; Minoru Kidokoro [Japon] ; Fukashi Murai [Japon] ; Mai Quynh Le [Viêt Nam] ; Kyosuke Mizuno [Japon] ; Kouji Matsushima [Japon] ; Michinori Kohara [Japon]SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus
000365 Gui-Mei Li [Japon] ; Yong-Gang Li [Japon, Thaïlande] ; Masanobu Yamate [Japon] ; Shu-Ming Li [Japon] ; Kazuyoshi Ikuta [Japon, Thaïlande]Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle
000388 Masaji Okada [Japon] ; Yoshinobu Okuno [Japon] ; Satomi Hashimoto [Japon] ; Yoko Kita [Japon] ; Noriko Kanamaru [Japon] ; Yasuko Nishida [Japon] ; Yoshie Tsunai [Japon] ; Ruriko Inoue [Japon] ; Hitoshi Nakatani [Japon] ; Reiko Fukamizu [Japon] ; Yumi Namie [Japon] ; Junko Yamada [Japon] ; Kyoko Takao [Japon] ; Ritsuko Asai [Japon] ; Ryoko Asaki [Japon] ; Tetsuo Kase [Japon] ; Yuji Takemoto [Japon] ; Shigeto Yoshida [Japon] ; J. S. M. Peiris [Hong Kong] ; Pei-Jer Chen [Taïwan] ; Naoki Yamamoto [Japon] ; Tatsuji Nomura [Japon] ; Isao Ishida [Japon] ; Shigeru Morikawa [Japon] ; Masato Tashiro [Japon] ; Mitsunori Sakatani [Japon]Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models
000393 Luisa Cervantes Barragan [Suisse, Mexique] ; Roland Zust [Suisse] ; Friedemann Weber [Allemagne] ; Martin Spiegel [Allemagne] ; Karl S. Lang [Suisse] ; Shizuo Akira [Japon] ; Volker Thiel [Suisse] ; Burkhard Ludewig [Suisse]Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon
000395 Yuuki Inoue [Japon] ; Nobuyuki Tanaka [Japon] ; Yoshinori Tanaka [Japon] ; Shingo Inoue [Japon] ; Kouichi Morita [Japon] ; MIN ZHUANG [Japon] ; Toshio Hattori [Japon] ; Kazuo Sugamura [Japon]Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted
000401 Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Kouji Sakai [Japon] ; Masayuki Saijo [Japon] ; Fumihiro Taguchi [Japon] ; Masaru Yokoyama [Japon] ; Ichiro Kurane [Japon] ; Shigeru Morikawa [Japon]Amino acid substitutions in the S2 region enhance severe acute respiratory syndrome coronavirus infectivity in rat angiotensin-converting enzyme 2-expressing cells
000405 Masahiro Ikejiri [Japon] ; Takayuki Ohshima [Japon] ; Keizo Kato [Japon] ; Masaaki Toyama [Japon] ; Takayuki Murata [Japon] ; Kunitada Shimotohno [Japon] ; Tokumi Maruyama [Japon]5'-O-Masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agents
000460 Tetsuya Mizutani [Japon] ; Shuetsu Fukushi [Japon] ; Daisuke Lizuka [Japon] ; Osamu Inanami [Japon] ; Mikinori Kuwabara [Japon] ; Hideaki Takashima [Japon] ; Hiroshi Yanagawa [Japon] ; Masayuki Saijo [Japon] ; Ichiro Kurane [Japon] ; Shigeru Morikawa [Japon]Inhibition of cell proliferation by SARS-CoV infection in Vero E6 cells
000462 Hiroaki Kariwa [Japon] ; Nobuhiro Fujii [Japon] ; Ikuo Takashima [Japon]Inactivation of SARS coronavirus by means of povidone-lodine, physical conditions and chemical reagents
000481 Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Masayuki Saijo [Japon] ; Ichiro Kurane [Japon] ; Fumihiro Taguchi [Japon] ; Masato Tashiro [Japon] ; Shigeru Morikawa [Japon]Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV
000493 Tamaki Okabayashi [Japon] ; Hiroaki Kariwa [Japon] ; Shin-Ichi Yokota [Japon] ; Shigeo Iki [Japon] ; Tomokazu Indoh [Japon] ; Noriko Yokosawa [Japon] ; Ikuo Takashima [Japon] ; Hiroyuki Tsutsumi [Japon] ; Nobuhiro Fujii [Japon]Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections
000510 Shiro Shigeta [Japon] ; Shuichi Mori [Japon] ; Toshihiro Yamase [Japon] ; Norio Yamamoto [Japon] ; Naoki Yamamoto [Japon]Anti-RNA vims activity of polyoxometalates
000537 Hiroshi Ishii [Japon] ; Satomi Asai [Japon] ; Takayoshi Suzuki [Japon] ; Kenji Eguchi [Japon] ; Hayato Miyachi [Japon]Virus-associated hemophagocytic syndrome in an international traveler as a differential diagnosis of SARS
000538 Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Masayuki Saijo [Japon] ; Shutoku Matsuyama [Japon] ; Naoko Miyajima [Japon] ; Fumihiro Taguchi [Japon] ; Shigeyuki Itamura [Japon] ; Ichiro Kurane [Japon] ; Shigeru Morikawa [Japon]Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein
000553 Masaji Okada [Japon] ; Yuji Takemoto [Japon] ; Yoshinobu Okuno [Japon] ; Satomi Hashimoto [Japon] ; Shigeto Yoshida [Japon] ; Yukari Fukunaga [Japon] ; Takao Tanaka [Japon] ; Yoko Kita [Japon] ; Sachiko Kuwayama [Japon] ; Yumiko Muraki [Japon] ; Noriko Kanamaru [Japon] ; Hiroko Takai [Japon] ; Chika Okada [Japon] ; Yayoi Sakaguchi [Japon] ; Izumi Furukawa [Japon] ; Kyoko Yamada [Japon] ; Makoto Matsumoto [Japon] ; Tetsuo Kase [Japon] ; Daphne E. Demello [États-Unis] ; J. S. M. Peiris [Hong Kong] ; Pei-Jer Chen [Taïwan] ; Naoki Yamamoto [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Tatsuji Nomura [Japon] ; Isao Ishida [Japon] ; Shigeru Morikawa [Japon] ; Masato Tashiro [Japon] ; Mitsunori Sakatani [Japon]The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice
000565 Naoyuki Masuda [Japon] ; Osamu Yamamoto [Japon] ; Masahiro Fujii [Japon] ; Tetsuro Ohgami [Japon] ; Jiro Fujiyasu [Japon] ; Toru Kontani [Japon] ; Ayako Moritomo [Japon] ; Masaya Orita [Japon] ; Hiroyuki Kurihara [Japon] ; Hironobu Koga [Japon] ; Shunji Kageyama [Japon] ; Mitsuaki Ohta [Japon] ; Hiroshi Inoue [Japon] ; Toshifumi Hatta [Japon] ; Masafumi Shintani [Japon] ; Hiroshi Suzuki [Japon] ; Kenji Sudo [Japon] ; Yasuaki Shimizu [Japon] ; Eiichi Kodama [Japon] ; Masao Matsuoka [Japon] ; Masatoshi Fujiwara [Japon] ; Tomoyuki Yokota [Japon] ; Shiro Shigeta [Japon] ; Masanori Baba [Japon]Studies of non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: Synthesis and structure-activity relationships of 2-cyano and 2-hydroxy thiazolidenebenzenesulfonamide derivatives
000570 Fawzia Afreen [Japon] ; S. M. A. Zobayed [Japon] ; Toyoki Kozai [Japon]Spectral quality and UV-B stress stimulate glycyrrhizin concentration of Glycyrrhiza uralensis in hydroponic and pot system
000621 Masayuki Saijo [Japon] ; Shigeru Morikawa [Japon] ; Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Hideki Hasegawa [Japon] ; Noriyo Nagata [Japon] ; Naoko Iwata [Japon] ; Ichiro Kurane [Japon]Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus
000636 Satoru Itoyama [Japon] ; Naoto Keicho [Japon] ; Minako Hijikata [Japon] ; Tran Quy [Viêt Nam] ; NGUYEN CHI PHI [Viêt Nam] ; HOANG THUY LONG [Viêt Nam] ; LE DANG HA [Viêt Nam] ; VO VAN BAN [Viêt Nam] ; Ikumi Matsushita [Japon] ; Hideki Yanai [Japon] ; Fumiko Kirikae [Japon] ; Teruo Kirikae [Japon] ; Tadatoshi Kuratsuji [Japon] ; Takehiko Sasazuki [Japon]Identification of an alternative 5'-untranslated exon and new polymorphisms of angiotensin-converting enzyme 2 gene : Lack of association with SARS in the vietnamese population
000641 YU ZHONG [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Tadahiro Takeda [Japon] ; Noriko Shimizu [Japon] ; Sayaka Yoshizaki [Japon] ; Yoshio Inagaki [Japon] ; Shinobu Matsuda [Japon] ; Gisho Honda [Japon] ; Nobutaka Fujii [Japon] ; Naoki Yamamoto [Japon]Highly potent anti-HIV-1 activity isolated from fermented Polygonum tinctorium Aiton
000657 Masanobu Yamate [Japon] ; Makiko Yamashita [Japon] ; Toshiyuki Goto [Japon] ; Shoutaro Tsuji [Japon] ; Yong-Gang Li [Japon] ; Jiranan Warachit [Japon] ; Mikihiro Yunoki [Japon] ; Kazuyoshi Ikuta [Japon]Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus
000679 Shiro Shigeta [Japon] ; Toshihiro Yamase [Japon]Current status of anti-SARS agents
000708 Yumiko Imai [Autriche] ; Keiji Kuba [Autriche] ; SHUAN RAO [République populaire de Chine] ; YI HUAN [République populaire de Chine] ; FENG GUO [République populaire de Chine] ; BIN GUAN [République populaire de Chine] ; PENG YANG [République populaire de Chine] ; Renu Sarao [Autriche] ; Teiji Wada [Autriche] ; Howard Leong-Poi [Canada] ; Michael A. Crackower [Canada] ; Akiyoshi Fukamizu [Japon] ; Chi-Chung Hui [Canada] ; Lutz Hein [Allemagne] ; Stefan Uhlig [Allemagne] ; Arthur S. Slutsky [Canada] ; CHENGYU JIANG [République populaire de Chine] ; Josef M. Penninger [Autriche]Angiotensin-converting enzyme 2 protects from severe acute lung failure
000786 Leo L. M. Poon [Hong Kong] ; Cynthia S. W. Leung [Hong Kong] ; Masato Tashiro [Japon] ; KWOK HUNG CHAN [Hong Kong] ; Bonnie W. Y. Wong [Hong Kong] ; KWOK YUNG YUEN [Hong Kong] ; YI GUAN [Hong Kong] ; Joseph S. M. Peiris [Hong Kong]Rapid detection of the severe acute respiratory syndrome (SARS) coronavirus by a loop-mediated isothermal amplification assay
000790 Mayuko Takeda-Shitaka [Japon] ; Daisuke Takaya [Japon] ; Chieko Chiba [Japon] ; Hirokazu Tanaka [Japon] ; Hideaki Umeyama [Japon]Protein Structure Prediction in Structure based drug design : Protein structure prediction in medicinal chemistry
000862 HONG THI CAM THAI [Japon] ; MAI QUYNH LE [Japon] ; CUONG DUC VUONG [Japon] ; Manmohan Parida [Japon] ; Harumi Minekawa [Viêt Nam] ; Tsugunori Notomi [Viêt Nam] ; Futoshi Hasebe [Japon] ; Kouichi Morita [Japon]Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021